Joanne Louise Viney
Independent DirectorDr. Joanne Louise Viney, also known as Jo, PhD, is Advisor of Nanopath Inc. She is Director of Zag Bio, Inc. She is Founder, President, Chief Executive Officer and Director of Seismic Therapeutic, Inc. since October 2021. Dr. Viney serves on the boards of directors of several private companies, including LabCentral. She served as an Independent Director at Graphite Bio, Inc. since March 2021 until March 21, 2024. Dr. Viney joined the Graphite Bio, Inc. in March 2021. She is a co-founder of Pandion Operations, Inc. (formerly known as Pandion Therapeutics, Inc.). (formerly known as Pandion Therapeutics Holdco LLC.) and serves as its Chief Scientific Officer since April 2017 and President since July 2019. Dr. Viney remained in her role at Pandion until October 2021. Dr. Viney served as Independent Director at Harpoon Therapeutics, Inc. since July 2020 until June 22, 2023. Dr. Viney served as a Member of Advisors at HotSpot Therapeutics, Inc until, 2021. She serves as Director at Quench Bio, Inc. Dr. Viney is an Independent Director of Finch Therapeutics Group, Inc since August 2019. Dr. Viney served as the President, Chief Scientific Officer, Secretary and Co-Founder of Pandion Therapeutics Inc. She served as Senior Vice President of the Drug Discovery organization at Biogen from November 2015 to November 2016. She served as Vice President, Immunology Research at Biogen Inc. from July 2011 to October 2015. Prior to Biogen, she worked at Amgen as Executive Director of Inflammation Research from September 2003 to April 2011. She served as a Director of Inflammation Research at Immunex Corporation from July 2002 to August 2003 (acquired by Amgen in 2002). Throughout her career, Dr. Viney has been passionate about workplace inclusiveness. From 2015 to 2020, she served on the Board of WEST, a non-profit organization supporting early to mid-career women and was WEST’s President for the 2017-2018 term. Dr. Viney has maintained longstanding membership with the Society for Mucosal Immunology (SMI) and American Society of Immunologists (AAI). She has served numerous terms on the SMI Board, was President from 2011-2013 and is Treasurer for the 2018-2020 term. Together with SMI colleagues and Nature Publishing Group, she launched the journal Mucosal Immunology. She is an Independent Director of Sionna Therapeutics, Inc. from January 06, 2025. In 2015, Dr. Viney received SMI’s Distinguished Service Award. Dr. Viney is a member of the Board of Directors for Quench Bio and Carogen Corp. She also serves on the Scientific Advisory Board for HotSpot Therapeutics and Vaxart Inc. Throughout her career, Dr. Viney has been an advocate for workplace inclusiveness. In 2020, she was chosen as one of FiercePharma’s Fiercest Women in Life Sciences. She received a Ph.D. in Gut immunology from the University of London, St. Bartholomew’s Hospital Medical School, University of London and a B.Sc. in biophysical science from the University of East London. She is a Co-Founder and Director of Zag Bio, Inc. She is Founder, President, Chief Executive Officer and Director of Seismic Therapeutic, Inc. since October 2021. Dr. Viney serves on the boards of directors of several private companies, including LabCentral. She served as an Independent Director at Graphite Bio, Inc. since March 2021 until March 21, 2024. Dr. Viney joined the Graphite Bio, Inc. in March 2021. She is a co-founder of Pandion Operations, Inc. (formerly known as Pandion Therapeutics, Inc.). (formerly known as Pandion Therapeutics Holdco LLC.) and serves as its Chief Scientific Officer since April 2017 and President since July 2019. Dr. Viney remained in her role at Pandion until October 2021. Dr. Viney served as Independent Director at Harpoon Therapeutics, Inc. since July 2020 until June 22, 2023. Dr. Viney served as a Member of Advisors at HotSpot Therapeutics, Inc until, 2021. She serves as Director at Quench Bio, Inc. Dr. Viney is an Independent Director of Finch Therapeutics Group, Inc since August 2019. Dr. Viney served as the President, Chief Scientific Officer, Secretary and Co-Founder of Pandion Therapeutics Inc. She served as Senior Vice President of the Drug Discovery organization at Biogen from November 2015 to November 2016. She served as Vice President, Immunology Research at Biogen Inc. from July 2011 to October 2015. Prior to Biogen, she worked at Amgen as Executive Director of Inflammation Research from September 2003 to April 2011. She served as a Director of Inflammation Research at Immunex Corporation from July 2002 to August 2003 (acquired by Amgen in 2002). Throughout her career, Dr. Viney has been passionate about workplace inclusiveness. From 2015 to 2020, she served on the Board of WEST, a non-profit organization supporting early to mid-career women and was WEST’s President for the 2017-2018 term. Dr. Viney has maintained longstanding membership with the Society for Mucosal Immunology (SMI) and American Society of Immunologists (AAI). She has served numerous terms on the SMI Board, was President from 2011-2013 and is Treasurer for the 2018-2020 term. Together with SMI colleagues and Nature Publishing Group, she launched the journal Mucosal Immunology. She is an Independent Director of Sionna Therapeutics, Inc. from January 06, 2025. In 2015, Dr. Viney received SMI’s Distinguished Service Award. Dr. Viney is a member of the Board of Directors for Quench Bio and Carogen Corp. She also serves on the Scientific Advisory Board for HotSpot Therapeutics and Vaxart Inc. Throughout her career, Dr. Viney has been an advocate for workplace inclusiveness. In 2020, she was chosen as one of FiercePharma’s Fiercest Women in Life Sciences. She received a Ph.D. in Gut immunology from the University of London, St. Bartholomew’s Hospital Medical School, University of London and a B.Sc. in biophysical science from the University of East London.
Positions
- Company NameSionna Therapeutics, Inc.Stock CodeSIONPositionIndependent DirectorColleagues
- MCMichael CloonanPresident, CEO & Director
- PJPaul J. ClancyIndependent Chairman
- EHElena H. RidloffCFO & Chief Business Officer
- GHGreg HurlbutCo-Founder & Senior VP of Discovery Research
- MMMark MunsonCo-founder
- ACAndy ChuVice President of Information & Technology
- LDLaurie D. StelzerIndependent Director
- JRJoshua ResnickIndependent Director
